Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 31-40 of 232 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Pathogenesis of aortic sclerosis: association with low BMI, tissue nitric oxide resistance, but not systemic inflammatory activationSverdlov, A.; Ngo, D.; Horowitz, J.
2012Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeuticsSverdlov, A.; Ngo, D.; Chan, W.; Chirkov, Y.; Gersh, B.; McNeil, J.; Horowitz, J.
2014High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarinHijazi, Z.; Wallentin, L.; Siegbahn, A.; Andersson, U.; Alexander, J.; Atar, D.; Gersh, B.; Hanna, M.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Granger, C.
2010Hydralazine does not ameliorate nitric oxide resistance in chronic heart failureChirkov, Y.; De Sciscio, M.; Sverdlov, A.; Leslie, S.; Sage, P.; Horowitz, J.
2013Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for Stroke prevention in atrial fibrillationHorowitz, J.
2009Clinical trials update from the European society of cardiology congress in Munich, 2008: TIME-CHF, CARESS-in-AMI, TRITON-TIMI 38, EUROPA, AF-CHF, and ADVANCEHorowitz, J.; Remme, W.; Torp-Pedersen, C.
2013N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: Insights from the aristotle trial (apixaban for the prevention of stroke in subjects with atrial fibrillation)Hijazi, Z.; Wallentin, L.; Siegbahn, A.; Andersson, U.; Christersson, C.; Ezekowitz, J.; Gersh, B.; Hanna, M.; Hohnloser, S.; Horowitz, J.; Huber, K.; Hylek, E.; Lopes, R.; McMurray, J.; Granger, C.
2011The calcium scare - what would Austin Bradford Hill have thought?Nordin, B.; Lewis, J.; Daly, R.; Horowitz, J.; Metcalfe, A.; Lange, K.; Prince, R.
2013Heart failure: a corin-deficient state?Ngo, D.; Horowitz, J.; Sverdlov, A.
2006Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosisChirkov, Y.; Mishra, K.; Chandy, S.; Holmes, A.; Kanna, R.; Horowitz, J.